A decrease in plasma membrane fluidity due to chronic overconsumption of saturated fat, endocrine disturbances (e.g., insulin resistance, hyperleptinemia, drop in the plasma GLP-1 levels), and/or inflammation related to obesity are plausible candidates. This evidence concerns the gene GCG and obesity disorder.